CHLOROQUINE AND HYDROXYCHLOROQUINE ARE AVAILABLE TREATMENT OPTIONS TO FIGHT WITH COVID-19
The corona virus SARS-CoV-2 caused pandemic Covid-19 disease. At present there is novaccine or drug approved by FDA to treat Covid-19 disease. The high fatality rate and extremefast spreading of disease in the community make researchers to invent possible therapeuticinventions a global priority. Rec...
Saved in:
| Main Authors: | Shadia S. Alhamd, Manal I. khaleel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
College of Veterinary Medicine, University of Basrah, Iraq
2020-11-01
|
| Series: | Basrah Journal of Veterinary Research |
| Subjects: | |
| Online Access: | https://bjvr.uobasrah.edu.iq/article_174120_84307e7a819549660d614eab0af0de66.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rheumotologitsts’ view on the use of hydroxychloroquine to treat COVID-19
by: Xiaoxuan Sun, et al.
Published: (2020-01-01) -
Hydroxychloroquine – Beyond Malaria: Its Role in Rheumatology and COVID-19 – A Literature Review
by: Adam Jan Ząbek, et al.
Published: (2025-04-01) -
Drug Interactions and Side Effects of Co-Administration of Chloroquine/Hydroxychloroquine and Azithromycin: on the Issue of Rational Pharmacotherapy of Patients with COVID-19 with Antimalarial Drugs
by: O. V. Gaisenok
Published: (2020-07-01) -
Usefulness of Hydroxychloroquine and Chloroquine in the Prevention of Malaria in Systemic Lupus Erythematosus: Experience from the University of Nigeria Teaching Hospital Enugu, Nigeria
by: Celestine C. Okwara, et al.
Published: (2025-07-01) -
A New <i>In Silico</i> Comparison of the Relative Affinity of Enantiomeric Chloroquine (CQ) and Hydroxychloroquine (HCQ) for ACE2
by: Carlos Naranjo-Castañeda, et al.
Published: (2025-06-01)